Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
GlobeNewswire
*Allschwil, Switzerland, May 16, 2024*
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage..
*Allschwil, Switzerland, May 16, 2024*
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage..
· *Clinical portfolio substantially strengthened through business development in 2023; two phase 3 studies expected to start in..
Mumbai-based *VAV Lipids*, one of the world's leading lipid manufacturers, has completed upgrading and expanding its EU..